Cover Story
Free
By Matthew Bin Han Ong
On Oct. 21, 1974, John Cleland lay in a hospital bed at Indiana University Hospital.
In Brief
Drugs & Targets
Trending Stories
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future - Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Our challenge: To find zen in chaos
- Foundations acquire a critical new role as federal funding for cancer research falters